In their 2005 study, Kim et al. [125] discovered that activation of the PI3K/AKT-signaling pathway not only stimulated the proliferation and differentiation of breast cancer cells but also inhibited cell apoptosis, consequently bolstering their resistance to chemotherapeutic agents [126,127,128,129,130]. Here, AKT1 is linked to breast cancer.